Skip to content

Neurentis PLC

ActivePublic limited company

Key figures

Year to 30 Nov 2025

Loss
£43.3k−£5.8kon prior year
Net assets
£2.1m−£33.3kon prior year
Total assets
£2.1m−£25.6kon prior year
Cash at bank
£49.5k+£12.3kon prior year
Employees
3
Balance sheetLast 3 filed years
Total assets, 2023: £2.1mTotal assets, 2024: £2.1mTotal assets, 2025: £2.1mNet assets, 2023: £2.1mNet assets, 2024: £2.1mNet assets, 2025: £2.1mTotal liabilities, 2023: £15.6kTotal liabilities, 2024: £16.4kTotal liabilities, 2025: £24k202320242025
  • Total assets£2.1m
  • Net assets£2.1m
  • Total liabilities£24k
EmployeesMicro employer · under 10 staff

From accounts filed with Companies House · FRS 102 accounts. Changes are against the prior year.

Accounts

Current period

2 weeks left

1 Dec 202530 Nov 2026
Next accounts due
31 May 2027
in 7 months
Last made up to
30 Nov 2025

Past periods

  • 1 Dec 2024 – 30 Nov 2025
  • 1 Dec 2023 – 30 Nov 2024

Details

Company number
14461527
Incorporated
4 November 2022
Registered office
47 Ashworth Mansions, Grantully Road, London, W9 1LW, England
Nature of business
  • Manufacture of basic pharmaceutical products 21100
  • Manufacture of pharmaceutical preparations 21200
Directors
  • Bijoy Kumar Premi
  • Dimitri Dimitriou
  • Dr Stephane Robert Georges Mery

See the full picture of Neurentis PLC

  • Financials, year by year
  • Filed accounts and documents
  • Ownership chart
Create a free account

Free, with 3 credits a month.

From Companies House, updated 26 Feb 2026.